WELCOME TO The PHARMACEUTICAL REPORT
BETTER BUILDINGS FOR BETTER PHARMACEUTICAL PRODUCTION
May 28, 2019
I'm For Real
Enter your details once to access all our information and resources
GlaxoSmithKline Pharma GmbH is a science-led global healthcare company. We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare.
whitePaper | July 7, 2022
The full drug target profile identification is many times a necessary step in drug development process. Recently, the move to a more holistic approach in drug discovery has resulted in the increasing use of cell-based assays to discover new biologically active small molecules.
whitePaper | December 9, 2022
There is an upward trend for pharmaceutical companies to ask their contract development and manufacturing organisations (CDMO) to support the conversion.
whitePaper | March 4, 2022
The pandemic has been healthcare and the pharmaceutical industry’s meteor moment established eco-systems have been wiped out andsales force routines have been scorched from the face of the earth.
whitePaper | December 16, 2022
commenced work on a new standard to provide a global policy to limit these impurities in drug products and
whitePaper | June 27, 2022
Following on from our review of trends in the current pharmaceutical R&D pipeline this supplement takes a look at the industry’s success stories of 2021
whitePaper | June 21, 2022
nduced-proximity targeted protein degradation (TPD) is a ground-breaking strategy in drug discovery that has emerged during the last decade.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE